The global ankylosing spondylitis treatment market reached a value of USD 5.02 billion in 2024 and is projected to grow at a CAGR of 8.10% from 2025 to 2034, attaining USD 10.94 billion by 2034. This growth is primarily driven by the increasing prevalence of ankylosing spondylitis, fueled by sedentary lifestyles and rising awareness of early diagnosis and treatment. https://www.expertmarketresearch.com/reports/ankylosing-spondylitis-treatment-market